Mounjaro® (tirzepatide) 5 mg Pen – A dual GIP and GLP-1 receptor agonist for adults with type 2 diabetes, administered once weekly via a pre-filled pen as part of the dose-escalation schedule following the 2.5 mg starting dose.
Mounjaro® (tirzepatide) 5 mg Pen – A dual GIP and GLP-1 receptor agonist for adults with type 2 diabetes, administered once weekly via a pre-filled pen as part of the dose-escalation schedule following the 2.5 mg starting dose.
Reviews
There are no reviews yet.